Quarterly Revenue Growth and Record High
Total Q4 revenue reached RMB 451 million, up ~25% year-over-year, marking a record high quarterly revenue and reflecting strong demand recovery.
Aesthetic Center Business Became Primary Growth Engine
Aesthetic treatment services revenue was RMB 248.1 million, up 205.3% year-over-year, crossing the 50% revenue contribution threshold and becoming the largest segment for the first time.
Rapid Network Expansion and Market Leadership by Center Count
Opened 49 So-Young clinics by year-end 2025 (net +10 in Q4), ranking first nationwide by center count and surpassing the 50-center milestone in early 2026.
Strong Treatment Volume and User Base Growth
Verified treatment visits exceeded 125,000 in Q4 (up 178% YoY); verified aesthetic treatments performed exceeded 289,400 (up 168% YoY); total active users surpassed 170,000.
Improving Unit Economics at Center Level
17 mature centers generated RMB 102.5 million (~RMB 8.4 million per mature center); 19 growth centers generated RMB 89 million (~RMB 4.7 million per center). 25 centers achieved profitability and 39 centers generated positive operating cash flow in Q4.
Physician Team Expansion and Clinical Capability
Full-time physician headcount grew to 211 (up 41% from end of Q3); all physicians have public hospital backgrounds, >6 years average clinical experience for the team, and >6,200 treatments per physician for those with ≥1 year at So-Young, supporting trust and service quality.
Supply Chain Scale and Product Mix Strength
Partnered with 18 top-tier device suppliers (nearly 1,400 devices procured) and 42 upstream injectables partners with cumulative procurement of >700,000 units; blockbuster products accounted for over 37% of aesthetic revenue in Q4.
Marketing/Brand Campaign Successes
Q4 co-branded campaigns generated ~2 million on-site visits and ~40 million total exposures, driving offline brand validation in high-end malls and improved conversion for flagship treatments.
Improved Loss Metrics and Solid Cash Runway
Net loss attributable to So-Young improved to RMB 108.8 million (vs. RMB 607.6 million prior-year period); basic and diluted loss per ADS improved to RMB 1.08 (vs. RMB 5.92). Cash, cash equivalents and short-term investments totaled RMB 936.4 million to fund expansion.
Confident 2026 Outlook and Growth-Plus-Profitability Plan
Guidance for Q4 2026 aesthetic treatment services revenue of RMB 258–278 million (up 171.2%–181.3% YoY) and a plan to open no fewer than 35 new centers in 2026 while shifting focus to improved gross margins and profitability.